This grant is for the purpose of establishing a Data Coordinating Center for the Molecular Atlas of Lung Development (LungMAP) program. The LungMAP program aims to construct a comprehensive molecular and cellular atlas of the human lung. This atlas will serve as a vital reference, enhancing the understanding of normal lung biology and disease pathobiology. It also seeks to identify critical cellular components, molecular pathways, and novel therapeutic targets for lung diseases. LungMAP is designed as an open-access resource, integrating diverse, high-resolution data. This information will define lung cells by gene expression, physiological states, 3D locations, and developmental or pathological trajectories.
Opportunity ID: 349293
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-24-007 |
| Funding Opportunity Title: | Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Data Coordinating Center (U24- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.838 — Lung Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 14, 2023 |
| Last Updated Date: | Jul 14, 2023 |
| Original Closing Date for Applications: | Oct 27, 2023 |
| Current Closing Date for Applications: | Oct 27, 2023 |
| Archive Date: | Dec 02, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,260,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Native American tribal governments (Federally recognized) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The objective of the Molecular Atlas of Lung Development (LungMAP) program is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. LungMAP is an open access resource integrating multi-scale, high-content, high-resolution information to define lung cells with gene expression, physiological states, 3-dimensional locations, as well as developmental and pathological trajectories. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 349293 Full Announcement-RFA-HL-24-007 -> RFA-HL-24-007-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00282565 | Sep 27, 2023 | Oct 27, 2023 | View |
Package 1
Mandatory forms
349293 RR_SF424_5_0-5.0.pdf
349293 PHS398_CoverPageSupplement_5_0-5.0.pdf
349293 RR_OtherProjectInfo_1_4-1.4.pdf
349293 PerformanceSite_4_0-4.0.pdf
349293 RR_KeyPersonExpanded_4_0-4.0.pdf
349293 RR_Budget_3_0-3.0.pdf
349293 PHS398_ResearchPlan_5_0-5.0.pdf
349293 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349293 RR_SubawardBudget30_3_0-3.0.pdf
349293 PHS_AssignmentRequestForm_3_0-3.0.pdf